e-Drug3D

959

REGADENOSON


INN
REGADENOSON

cas 313348-27-5
CLASS

CARDIOVASCULAR
A2A ADENOSINE RECEPTOR AGONIST (KI = 1.3 MICROMOLAR)
CORONARY VASODILATOR

ROUTE (list)

INTRAVENOUS

ATC code

C01EB21

PK parameters

Tmax 0.08 HOUR
VD 11.5 LITER
t1/2 2 HOUR

Target

TARGET A2A ADENOSINE RECEPTOR

DrugCentral

Adenosine receptor A2a UNIPROT P29274 ADORA2A

Download SDF file Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-

Formula:
C15H18N8O5

Calculated chemical properties:

MW 390.37
NB_atoms 28
XLogP -2.43
PSA 177.258
NB_HD 6
NB_HA 13
fsp3 0.40
Lipinski(0=no;1=yes) 0

FDA
NDA 022161 (label) INN (REGADENOSON) LEXISCAN (ASTELLAS) APPROVAL= AP YEAR= 2008
NDA 207604 (pdf not found) INN (REGADENOSON) REGADENOSON (APOTEX) APPROVAL= AP YEAR= 2022
NDA 213210 (pdf not found) INN (REGADENOSON) REGADENOSON (DR REDDYS) APPROVAL= AP YEAR= 2022
NDA 212806 (pdf not found) INN (REGADENOSON) REGADENOSON (MEITHEAL) APPROVAL= AP YEAR= 2022
NDA 213236 (pdf not found) INN (REGADENOSON) REGADENOSON (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2022
NDA 214252 (pdf not found) INN (REGADENOSON) REGADENOSON (IMS LTD) APPROVAL= AP YEAR= 2022
NDA 207320 (pdf not found) INN (REGADENOSON) REGADENOSON (GLAND) APPROVAL= AP YEAR= 2022
NDA 214349 (pdf not found) INN (REGADENOSON) REGADENOSON (HOSPIRA) APPROVAL= AP YEAR= 2022
NDA 216437 (pdf not found) INN (REGADENOSON) REGADENOSON (EUGIA PHARMA) APPROVAL= AP YEAR= 2022
NDA 213856 (pdf not found) INN (REGADENOSON) REGADENOSON (MYLAN) APPROVAL= AP YEAR= 2023
NDA 215827 (pdf not found) INN (REGADENOSON) REGADENOSON (HIKMA) APPROVAL= AP YEAR= 2023
NDA 217455 (pdf not found) INN (REGADENOSON) REGADENOSON (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2023
NDA 215955 (pdf not found) INN (REGADENOSON) REGADENOSON (GE HEALTHCARE) APPROVAL= AP YEAR= 2024
NDA 218054 (pdf not found) INN (REGADENOSON) REGADENOSON (INDIES PHARMA) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL